If you need more lookups,
subscriptions start at $34 USD/month.
Lynne Murray Location
United Kingdom
Lynne Murray Work
2025 -now CEO @
2024 -2025 Venture Partner @
2022 -2024 VP, Head of UK Research, Site Head for Oxford @
2022 -2024 Chief Scientific Officer @
2022 -2024 Chief Scientific Officer @
2020 -2022 SVP R and D @
2018 -2020 Respiratory, Inflammation, Autoimmunity (RIA) IMED Biotech unit @
2013 -2018 Partnering and Strategy @ MedImmune
2009 -2013 Head of Biology-Fibrosis @ MedImmune
2007 -2010 Secretary @ Pulmonary Research Group
2007 -2009 Director, Pharmacology @ Promedior, Inc.
2004 -2007 Research Scientist @ Centocor
2000 -2003 PhD @
now Scientist @
now Research @
Lynne Murray Education
University of Cambridge
MBA
2011-2013
UCLA
PostDoc (Pulmonary and Crit Care Medicine)
2003-2004
Imperial College London
PhD (Immunology and Pathology)
2000-2003
King's College London
BSc (Pharmacology)
1995-1999
Lynne Murray Skills
Lifesciences
Immunology
Drug Discovery
In Vitro
In Vivo
Pharmacology
Assay Development
Biomarkers
Clinical Development
Biotechnology
Translational Medicine
Drug Development
Animal Models
Cell
Cell Biology
Biopharmaceuticals
High Throughput Screening
Cell Culture
Pharmaceutical Industry
Strategic Planning
Management
Leadership
Life Sciences
PowerPoint
Strategy
Business Strategy
Public Speaking
Lynne Murray Summary
Lynne Murray, based in United Kingdom, is currently a CEO at Stealth Biotech. Lynne Murray brings experience from previous roles at SR One Capital Management, Gilead Sciences and MiroBio Ltd. Lynne Murray holds a 2011 - 2013 MBA @ University of Cambridge. With a robust skill set that includes Lifesciences, Immunology, Drug Discovery, In Vitro, In Vivo and more. Lynne Murray has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Lynne Murray?
Find contact details for 700 million professionals.